Sometimes in medtech we tend to have an exceptionalism attitude—and, in part, it is justified. Our industry is unique and complex compared to many others. For instance, our unique sales process (the third-party payer system, no end-user decision makers, etc.) is one that only other healthcare companies can understand. But as we all know, we’re also not exactly like other healthcare industries. For example, decisions around the business model are very relevant to many medtech companies but are often overlooked in the pharmaceutical industry.
Read MoreBy using this site, you are consenting to the use of cookies on your device. For details, please view our privacy policy.